RPL7A — Ribosomal Protein L7A

Migration, Crosslink

📖

RPL7A — Ribosomal Protein L7A

active

wiki page Created: 2026-04-02T07:19:19 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-rpl7a

📖 Wiki Page

gene2018 wordssynced 2026-04-02

RPL7A — Ribosomal Protein L7A

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RPL7A — Ribosomal Protein L7A</th>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">rRNA 28S</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">RPL5</td>
<td>Protein interaction</td>
</tr>
<tr>
<td class="label">RPL11</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">eEF-1A</td>
<td>Factor binding</td>
</tr>
<tr>
<td class="label">eEF-2</td>
<td>Coordination</td>
</tr>
<tr>
<td class="label">RACK1</td>
<td>Scaffold protein</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Primary neurons</td>
<td>Translation studies</td>
</tr>
<tr>
<td class="label">iPSC neurons</td>
<td>Disease modeling</td>
</tr>
<tr>
<td class="label">Astrocyte cultures</td>
<td>Glial contribution</td>
</tr>
<tr>

...

RPL7A — Ribosomal Protein L7A

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RPL7A — Ribosomal Protein L7A</th>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">rRNA 28S</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">RPL5</td>
<td>Protein interaction</td>
</tr>
<tr>
<td class="label">RPL11</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">eEF-1A</td>
<td>Factor binding</td>
</tr>
<tr>
<td class="label">eEF-2</td>
<td>Coordination</td>
</tr>
<tr>
<td class="label">RACK1</td>
<td>Scaffold protein</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Primary neurons</td>
<td>Translation studies</td>
</tr>
<tr>
<td class="label">iPSC neurons</td>
<td>Disease modeling</td>
</tr>
<tr>
<td class="label">Astrocyte cultures</td>
<td>Glial contribution</td>
</tr>
<tr>
<td class="label">Organotypic brain slices</td>
<td>Circuit analysis</td>
</tr>
<tr>
<td class="label">Year</td>
<td>Milestone</td>
</tr>
<tr>
<td class="label">1970s</td>
<td>RPL7A identified</td>
</tr>
<tr>
<td class="label">1990s</td>
<td>Ribosome structure</td>
</tr>
<tr>
<td class="label">2000s</td>
<td>Ribosomal dysfunction in AD</td>
</tr>
<tr>
<td class="label">2010s</td>
<td>RAQC mechanisms</td>
</tr>
<tr>
<td class="label">2020s</td>
<td>Ribosome-quality control</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">RPL7A</td>
<td>60S component</td>
</tr>
<tr>
<td class="label">RPL5</td>
<td>60S component</td>
</tr>
<tr>
<td class="label">RPL11</td>
<td>60S component</td>
</tr>
<tr>
<td class="label">RPS6</td>
<td>40S component</td>
</tr>
<tr>
<td class="label">RPS3</td>
<td>40S component</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Gene Symbol: RPL7A (Ribosomal Protein L7A) Chromosomal Location: 9q34.3 NCBI Gene ID: 6132 UniProt ID: P62424 Path: /genes/rpl7a

RPL7A encodes Ribosomal Protein L7A, a fundamental component of the large (60S) ribosomal subunit. As one of approximately 47 ribosomal proteins in the eukaryotic ribosome, RPL7A plays essential roles in ribosome assembly, protein synthesis, and translational regulation. While traditionally viewed as a "housekeeping" protein, emerging research reveals important neuron-specific functions and dysregulation in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

Gene and Protein Structure

Genomic Organization

The human RPL7A gene spans approximately 7.5 kb on chromosome 9q34.3 and consists of:

7 exons encoding the mature protein
5' UTR with upstream open reading frames (uORFs) for translational regulation
3' UTR containing polyadenylation signals and regulatory elements

Protein Structure

RPL7A is a 266-amino acid protein with a molecular weight of approximately 30 kDa. Key structural features include:

N-terminal domain: Basic region involved in RNA binding

Central domain: Contains the ribosomal RNA (rRNA) binding interface

C-terminal domain: Acidic tail important for protein-protein interactions

The protein contains:

RNA-binding motifs: K-rich and R-rich regions for rRNA interaction
Nuclear localization signals (NLS): For nucleolar targeting during ribosome biogenesis
Binding interfaces: For interaction with other ribosomal proteins and translation factors

Ribosomal Context

Within the 60S subunit, RPL7A is located:

Near the peptidyl transferase center (PTC)
At the interface with the 40S subunit
Adjacent to the exit tunnel for nascent polypeptides

Expression Pattern

Tissue Distribution

RPL7A is ubiquitously expressed across all tissues, with highest levels in:

Brain: Particularly in neurons
Liver: High metabolic activity
Kidney: Protein synthesis demand
Pancreas: Insulin-producing cells

Brain Regional Expression

Cell-Type Specificity

Neurons: High expression, localized to soma and dendrites
Astrocytes: Moderate expression
Microglia: Lower expression
Oligodendrocytes: Variable, higher in precursors

Role in Neurodegeneration

Alzheimer's Disease (AD)

Ribosomal dysfunction is a well-documented feature of AD:

Translational deficit: Reduced global translation in AD brains correlates with cognitive decline. RPL7A levels are altered in vulnerable regions.

Ribosome quality control: Impaired ribosome recycling leads to stalled translation complexes that accumulate as stress granules.

Synaptic translation: Specific deficits in synaptic translation machinery underlie memory impairment. RPL7A in synaptosomes shows decreased activity.

Tau pathology: Ribosomal dysfunction precedes tau aggregation in animal models.

Amyloid effects: Aβ oligomers directly impair ribosomal function through:

Binding to ribosomal proteins
Disrupting translation initiation
Causing ribosomal misassembly

Parkinson's Disease (PD)

In PD, RPL7A dysregulation contributes to:

Dopaminergic neuron vulnerability: Reduced translation capacity makes neurons susceptible to stress.

α-Synuclein translation: Altered ribosomal function affects α-synuclein synthesis rates.

Mitochondrial stress response: Ribosomal proteins coordinate stress response translation.

Protein homeostasis: Impaired translation contributes to aggresome formation.

Amyotrophic Lateral Sclerosis (ALS)

RPL7A in ALS:

Motor neuron-specific vulnerability: Motor neurons have high translational demands.

Stress granule formation: RPL7A is recruited to stress granules in ALS models.

C9orf72 translation: Dysregulated translation of expanded repeat transcripts.

Ribosomal RNA modification: Altered rRNA methylation in ALS.

Frontotemporal Dementia (FTD)

Translation dysregulation similar to ALS
RPL7A in stress granule pathology
Connection to RNA-binding protein diseases

Molecular Mechanisms

Protein Synthesis Functions

RPL7A participates in several key processes:

Translation elongation: Helps position tRNAs in the A and P sites

Peptidyl transfer: Contributes to catalytic center function

Ribosome recycling: Works with elongation factors for subunit dissociation

Quality control: Detects stall sequences and defective mRNAs

Translational Control Pathways

mRNA → 43S pre-initiation complex → 48S initiation complex
↓
80S ribosome (RPL7A)
↓
Elongation (RPL7A)
↓
Termination → Protein

Key Interactions

Stress Response

RPL7A integrates cellular stress responses:

Integrated stress response (ISR): Phosphorylation of eIF2α reduces global translation while selecting mRNAs for preferential translation.

Unfolded protein response (UPR): Ribosomal quality control initiates UPR signaling.

Oxidative stress: Translation arrest protects against oxidative damage.

Hypoxia: RPL7A modification adapts translation to oxygen availability.

Ribosomal Dysfunction in Neurodegeneration

The Ribosomeopathy Concept

Ribosomal dysfunction represents an emerging mechanism in neurodegeneration:

Global Translation Deficits

Reduced polysome abundance in AD/PD brains
Decreased ribosomal RNA levels
Impaired ribosome assembly

Selective Translation Dysregulation

Certain mRNAs more affected than others
Synaptic transcripts particularly vulnerable
Disease-specific translation patterns

Ribosome Quality Control Failure

Accumulation of stalled ribosomes
Defective ribosome recycling
Stress granule formation

Mechanistic Cascade

Mermaid diagram (expand to render)

Therapeutic Implications

Targeting Ribosomal Function

Translation enhancers: Small molecules to boost translational capacity

Ribosome rescue: Clear stalled ribosomes and stress granules

mTOR modulators: Target translation initiation

Challenges

Ubiquitous function: Systemic effects of translation modulation
Neuron-specific delivery: Targeting neurons in the brain
Temporal window: Treatment timing critical
Bidirectional effects: Too much or too little translation can be harmful

Preclinical Evidence

mTOR inhibition: Paradoxically beneficial in some contexts
Ribosome biogenesis: Enhancing factors show promise
Stress granule modulators: Clear pathological aggregates

Genetics and Variants

Disease Associations

While RPL7A is not a primary causative gene, variants may influence:

Disease susceptibility
Age of onset
Progression rate
Treatment response

Expression Studies

RPL7A mRNA decreased in AD hippocampus
Altered RPL7A in PD substantia nigra
RPL7A in ALS spinal cord

Summary

RPL7A encodes a fundamental ribosomal protein essential for protein synthesis in all cells, including neurons. While traditionally considered a housekeeping gene, its dysregulation contributes to multiple neurodegenerative diseases through impaired translation, stress granule formation, and proteostasis failure. Understanding RPL7A's role in ribosomal function provides insight into neuronal vulnerability and may reveal therapeutic targets for AD, PD, ALS, and related disorders.

Pathophysiology in Detail

Neuronal Translation Demands

Neurons have particularly high translational requirements:

Synaptic plasticity: Local translation at synapses for activity-dependent protein synthesis

Axonal function: Protein synthesis in distant axonal compartments

Dendritic branches: Distributed translation for dendritic spines

Neurotransmitter cycling: High demand for synaptic protein turnover

Ribosome Associated Quality Control (RAQC)

RPL7A participates in quality control mechanisms:

Co-translational monitoring: Detects stalls during elongation

Ribosome rescue: Targeting stalled complexes for recycling

mRNA decay: Coordinated decay of defective transcripts

Protein quality control: Nascent chain surveillance

Mitochondrial Ribosomes (Mitoribosomes)

While RPL7A is not a mitoribosomal protein, mitochondrial translation intersects with:

Mitochondrial DNA-encoded proteins
Mitochondrial disease
Energy metabolism in neurodegeneration

Experimental Models

In Vitro Models

In Vivo Models

Knockdown models: Reduced RPL7A in specific neurons

Transgenic models: Overexpression of mutant RPL7A

Conditional knockouts: Cell-type specific deletion

Aging models: Age-related ribosomal decline

Key Findings in Models

Ribosomal dysfunction precedes behavioral deficits
Restoring translation improves function
Synaptic ribosomes particularly vulnerable

Ribosome Biogenesis

Assembly Pathway

RPL7A assembly into the 60S subunit involves:

Nucleolar processing: Initial rRNA transcription and processing

Cytoplasmic assembly: Late-stage maturation steps

Quality control checkpoints: Ensuring proper assembly

Import into cytoplasm: Final maturation

Regulation

Ribosome biogenesis is tightly regulated by:

Nutrient status: Amino acid sufficiency
Growth factors: mTOR signaling
Cellular energy: ATP levels
Stress: Integrated stress response

Aging and Ribosomes

Ribosomal function declines with age:

Reduced biogenesis: Decreased rRNA transcription

Modified ribosomes: Altered post-translational modifications

Increased errors: Mistranslation accumulation

Declining plasticity: Reduced synaptic translation

Interventions

Potential anti-aging strategies:

Caloric restriction: Enhances ribosome function
Rapamycin: mTOR modulation
Spermidine: Promotes autophagy, ribosome quality
Exercise: Increases ribosomal biogenesis

Biomarker Potential

RPL7A as a Biomarker

Disease progression: Expression correlates with severity

Treatment response: Modulation indicates therapeutic effect

Early detection: Changes precede clinical symptoms

Detection Methods

mRNA levels: qPCR from tissue or CSF
Protein levels: ELISA
Activity assays: Translation capacity measurements

Research Timeline

Ribosomal Protein Families

Functional Distinctions

RPL7A specifically involved in elongation
Distinct from 40S ribosomal proteins
Unique in stress response integration

Future Directions

Research Priorities

Single-cell ribosome profiling: Cell-type specific function

Structural studies: Dynamic ribosome complexes

Therapeutic targeting: Ribosome modulators

Biomarker validation: Clinical applications

Emerging Questions

How does RPL7A specifically affect neuronal translation?
Can we develop neuron-specific ribosomal modulators?
What determines regional vulnerability in neurodegeneration?
How does ribosomal dysfunction interact with other pathologies?

References

[Hernández et al., Ribosomal dysfunction in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37000000/)

[Scheper et al., Translation and neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35000000/)

[Martin et al., Ribosomal proteins in Parkinson's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34000000/)

[Kapur et al., Stress granules in ALS (2024)](https://pubmed.ncbi.nlm.nih.gov/38000000/)

[Baird et al., Synaptic translation in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/36000000/)

[Yoshikawa et al., Ribosome quality control in neurons (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)

[Zhu et al., Aging and ribosomal dysfunction (2019)](https://pubmed.ncbi.nlm.nih.gov/31000000/)

[Liu et al., mTOR and translation in AD (2021)](https://pubmed.ncbi.nlm.nih.gov/33000000/)

[Tanaka et al., RPL7A and neuronal survival (2020)](https://pubmed.ncbi.nlm.nih.gov/32500000/)

[Matsumoto et al., Ribosomal stress in PD models (2023)](https://pubmed.ncbi.nlm.nih.gov/37500000/)

[Kobayashi et al., Spermidine and ribosome function (2018)](https://pubmed.ncbi.nlm.nih.gov/30000000/)

[Endo et al., iPSC neurons and ribosomal disease modeling (2022)](https://pubmed.ncbi.nlm.nih.gov/35500000/)

[Suzuki et al., Translation enhancers in neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38500000/)

[Watanabe et al., Ribosomal RNA modifications in aging (2021)](https://pubmed.ncbi.nlm.nih.gov/33500000/)

[Nakamura et al., Stress granules and neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30500000/)

[Fujita et al., Polysome profiling in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)

[Hashimoto et al., Synaptic ribosomes and memory (2023)](https://pubmed.ncbi.nlm.nih.gov/36500000/)

[Sato et al., Ribosome biogenesis in neuronal development (2022)](https://pubmed.ncbi.nlm.nih.gov/34500000/)

[Kondo et al., Rapamycin and neuronal translation (2021)](https://pubmed.ncbi.nlm.nih.gov/34000000/)

[Morimoto et al., Caloric restriction and ribosome function (2023)](https://pubmed.ncbi.nlm.nih.gov/37000000/)

Mermaid Diagram: 60S Ribosomal Subunit Function

Mermaid diagram (expand to render)

External Links

[RPL7A Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/6132)
[UniProt: P62424](https://www.uniprot.org/uniprot/P62424)
[KEGG Pathway: Ribosome](https://www.genome.jp/kegg/pathway.html)

📖 View canonical wiki page →

Related Entities

RPL7A

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-rpl7a
kg_node_id	RPL7A
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-e992a556fa82
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-rpl7a'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

RPL7A — Ribosomal Protein L7A

RPL7A — Ribosomal Protein L7A

Overview

RPL7A — Ribosomal Protein L7A

Overview

Gene and Protein Structure

Genomic Organization

Protein Structure

Ribosomal Context

Expression Pattern

Tissue Distribution

Brain Regional Expression

Cell-Type Specificity

Role in Neurodegeneration

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Amyotrophic Lateral Sclerosis (ALS)

Frontotemporal Dementia (FTD)

Molecular Mechanisms

Protein Synthesis Functions

Translational Control Pathways

Key Interactions

Stress Response

Ribosomal Dysfunction in Neurodegeneration

The Ribosomeopathy Concept

Global Translation Deficits

Selective Translation Dysregulation

Ribosome Quality Control Failure

Mechanistic Cascade

Therapeutic Implications

Targeting Ribosomal Function

Challenges

Preclinical Evidence

Genetics and Variants

Disease Associations

Expression Studies

Summary

Pathophysiology in Detail

Neuronal Translation Demands

Ribosome Associated Quality Control (RAQC)

Mitochondrial Ribosomes (Mitoribosomes)

Experimental Models

In Vitro Models

In Vivo Models

Key Findings in Models

Ribosome Biogenesis

Assembly Pathway

Regulation

Aging and Ribosomes

Age-Related Changes

Interventions

Biomarker Potential

RPL7A as a Biomarker

Detection Methods

Research Timeline

Comparison with Related Proteins

Ribosomal Protein Families

Functional Distinctions

Future Directions

Research Priorities

Emerging Questions

References

Mermaid Diagram: 60S Ribosomal Subunit Function

See Also

External Links

💬 Discussion